SlideShare a Scribd company logo
1 of 35
Journal presentation
Dr. Md. Mostafa-Al-Rasel
IMO (Medicine)
Medicine Unit-5
ShSMCH
‘Global, Regional, and Country-Specific
Lifetime Risks of Stroke, 1990 and 2016’
• Source: The New England Journal of Medicine
• Date of Publication: December 20, 2018
Introduction
 Stroke accounts for almost 5% of all disability-
adjusted life-years and 10% of all deaths worldwide
 The bulk of this burden (>75% of deaths from stroke
and >80% of disability-adjusted life-years) occurring
in low-income and middle-income countries.
 According to several surveys, the global burden of
stroke has been increasing, and prevention of stroke
may require an improved understanding of the risks
among younger persons.
 Stroke prevention strategies in low-income and
middle-income countries may differ from those
adopted in high-income countries owing to
differences in access to health care, health
technologies, and relative rates of risk factors for
stroke.
Introduction
• Estimates of lifetime risk (defined as the
cumulative probability of a disease developing
in a person of a given age and sex during that
person’s remaining lifespan, after accounting
for competing risks of death) provide a measure
of disease risk in large populations.
• Estimates of lifetime risk of stroke may be
useful for the long-term planning of health
systems
Introduction
• Researchers used the results of the Global Burden of
Disease (GBD) Study 2016, which estimated major
disease burden from 1990 through 2016, to
compare the estimated global, regional, and
country-specific lifetime risks of stroke in 2016 with
those in 1990.
• These estimates were stratified according to
pathological subtype of stroke, age, sex, and socio-
demographic index (SDI) and accounted for the
competing risk of death from any cause other than
stroke.
• The GBD is an ongoing global collaboration that uses
all available epidemiologic data to provide a
comparative assessment of health loss from 328
diseases across 195 countries and territories.
Background
• The lifetime risk of stroke has been calculated in a
limited number of selected populations.
• Diverging trends in stroke incidence and mortality
rates have been observed between developed
countries (where the rates are decreasing) and
developing countries (where the rates are
increasing) against a background of increasing life
expectancy in almost all countries.
• Investigators sought to estimate the lifetime risk of
stroke at the regional, country, and global level using
data from a comprehensive study of the prevalence
of major diseases.
Methods
• Place of study – global, regional (21 GBD
regions nested within 7 GBD super-regions),
and national (195 countries) levels
• Study period – from 1990 through 2016
• Funded by - the Bill and Melinda Gates
Foundation
Methods
Estimating Stroke Incidence and Mortality
 Researchers used estimates from the GBD Study 2016
of the rate of first stroke, cause-specific mortality, and
all-cause mortality at the global, regional (21 GBD
regions nested within 7 GBD super-regions), and
national (195 countries) levels, stratified according to
age and sex.
 Analyses were performed separately for ischemic
stroke and hemorrhagic stroke; the latter included
intracerebral hemorrhagic stroke and non traumatic
subarachnoid hemorrhagic stroke.
Methods
Estimating Lifetime Risk of Stroke
• Countries were categorized into quintiles of the SDI
(high, high-medium, medium, medium-low, and
low level of development) used in the GBD Study
2016.
• The SDI, a composite indicator of development
similar to the Human Development Index, is based
on country-level income per capita, average
educational attainment among persons older than
15 years of age, and total fertility rate.
• Researchers used stroke incidence, prevalence, and
mortality rates in each 5-year age group to estimate
the lifetime risk of stroke among persons at a given
age.
 Mortality was estimated by means of the
Cause of Death Ensemble model, in which vital
registration, verbal autopsy data were considered.
 Stroke incidence was estimated with the use of
DisMod-MR, a Bayesian meta-regression disease
modeling tool.
Statistical analysis
Statistical analysis
• Point estimates and 95% uncertainty intervals
representing the 2.5th and 97.5th percentiles
around the estimate were used to compare
results between groups.
• Differences in the estimates of the risk of stroke
were considered to be significant when the 95%
uncertainty intervals did not overlap or when the
95% uncertainty interval for relative percentage
change did not include zero.
Results
Results
• In 2016, the global lifetime risk of stroke from the
age of 25 years onward was 24.9% (95%
uncertainty interval, 23.5 to 26.2), and there
were regional and between-country differences.
• China had the highest estimated risk (39.3%; 95%
uncertainty interval, 37.5 to 41.1), and the risks
were similarly high in Bosnia and Herzegovina,
Bulgaria, Latvia, Macedonia, Montenegro,
Romania, and Russia.
Results
• Among the 21 GBD regions, East Asia had the
highest risk (38.8%; 95% uncertainty interval,
37.0 to 40.6), followed by Central Europe
(31.7%; 95% uncertainty interval, 30.0 to 33.3)
and Eastern Europe (31.6%; 95% uncertainty
interval, 27.6 to 35.6); eastern sub-Saharan
Africa had the lowest risk (11.8%; 95%
uncertainty interval, 10.9 to 12.8).
Results
• When the risks were compared across SDI
quintiles, the high-middle–SDI countries had
the greatest risk (31.1%; 95% uncertainty
interval, 29.0 to 33.0), followed by the middle-
SDI countries (29.3%; 95% uncertainty interval,
27.8 to 30.8);
• The low-SDI countries had the lowest risk
(13.2%; 95% uncertainty interval, 12.3 to 14.2).
• The risk was 23.5% (95% uncertainty interval,
22.2 to 24.8) in high-SDI countries.
Results
• In 2016, the global lifetime risk of stroke among
men (24.7%; 95% uncertainty interval, 23.3 to
26.0) was not significantly different from that
among women (25.1%; 95% uncertainty interval,
23.7 to 26.5), but there were regional and
between-country differences in sex-specific risk.
• The greatest risk among men was in China
(41.1%; 95% uncertainty interval 39.2 to 42.9);
among women in China, the risk was 36.7% (95%
uncertainty interval, 35.0 to 38.6), which
accounted for the largest difference in risk
between men and women among the nations.
Results
• The greatest risk among women was in Latvia
(41.7%; 95% uncertainty interval, 37.7 to
45.4), and the risks among women in Albania,
Belarus, Bosnia and Herzegovina, Bulgaria,
Lithuania, Macedonia, Monte-negro, Romania,
Russia, Serbia, Slovakia, and Ukraine were
similar.
Result
• The estimates of global lifetime risk of stroke
increased from 22.8% in 1990 to 24.9% in 2016,
representing a relative increase of 8.9% (95%
uncertainty interval, 6.2 to 11.5)
• The difference is significant, as reflected by the
exclusion of zero in the uncertainty interval.
• The increase in the risk was greater among men
(15.4%; 95% uncertainty interval, 12.5 to 18.2)
than among women (3.2%; 95% uncertainty
interval, 0.2 to 6.1), and the increase in the risk of
ischemic stroke (12.7%; 95% uncertainty interval,
8.9 to 16.3) was greater than that of hemorrhagic
stroke (4.0%; 95% uncertainty interval, 0.2 to
7.6).
Discussion
• The global lifetime risk of stroke from the age
of 25 years onward is estimated to have
increased from 22.8% in 1990 to 24.9% in
2016, with the change in the risk of ischemic
stroke exceeding that of hemorrhagic stroke.
• The estimated global lifetime risk of stroke has
declined with increasing age, in part owing to
age-related competing risks of other diseases.
Discussion
• In the comparative risk assessment performed
in the GBD Study, elevated blood pressure
was estimated as the leading attributable risk
factor for stroke across all SDI quintiles, with
greater attribution to air pollution and low
intake of fruit in low-SDI countries and high
body-mass index and high fasting plasma
glucose levels in high-SDI countries.
Discussion
• Knowledge of lifetime risk may be useful for
stroke prevention and public education.
• High estimates of lifetime risk of stroke
suggest that there is possible value of
measures for the primary prevention of stroke
throughout a person’s lifespan and suggest
that strategies to reduce cardiovascular risk
remain relevant for both younger and older
adults.
Strength
• The systematic use of data and methods that
allow for comparable estimates of lifetime risk of
stroke among different locations and between
different years.
• Researchers provide estimates of lifetime risk of
stroke only among persons 25 years of age or
older in contrast to other studies that estimated
lifetime risk of stroke among persons 45 years of
age or older.
• Furthermore, the estimates of lifetime risk of
stroke that we provide account for competing risk
of death from any cause other than stroke and
represent whole populations, possibly making the
results generalizable.
Limitation
• The accuracy of the estimates of lifetime risk of
stroke was limited by the accuracy and
availability of epidemiologic data from the
countries studied.
• There was a lack of sufficient epidemiologic
data on stroke incidence and case fatality for
most countries in the world.
• In these countries, estimates were dependent
on geospatial statistical models that
incorporated data from neighboring countries
and data on country-level risk exposure.
Limitation
• Researchers did not differentiate between
subarachnoid hemorrhagic and intracerebral
hemorrhagic stroke; these were combined in
the estimate of hemorrhagic stroke.
• Finally, researchers analyzed only the lifetime
risk of first-ever stroke and not recurrent
stroke.
Conclusion
• The study provided global, regional, and
country-specific estimates of the lifetime risk
of stroke according to sex and age.
• In 2016, the global lifetime risk of stroke from
the age of 25 years onward was approximately
25% among both men and women.
• There was geographic variation in the lifetime
risk of stroke, with the highest risks in East
Asia, Central Europe, and Eastern Europe.
Stroke journal
Stroke journal
Stroke journal
Stroke journal

More Related Content

What's hot

Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...UKFacultyPublicHealth
 
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...appfromlab
 
non communicable diseases of india
non communicable diseases of indianon communicable diseases of india
non communicable diseases of indiaswasthyasanchar
 
Global Burden of Disease Study - 2010
Global Burden of Disease Study - 2010Global Burden of Disease Study - 2010
Global Burden of Disease Study - 2010Rizwan S A
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsmonkmartinez
 
Cardiovascular diseases traditional_and_non-tradit
Cardiovascular diseases traditional_and_non-traditCardiovascular diseases traditional_and_non-tradit
Cardiovascular diseases traditional_and_non-traditArhamSheikh1
 
Physical activity and risk of cardiovascular disease—a
Physical activity and risk of cardiovascular disease—aPhysical activity and risk of cardiovascular disease—a
Physical activity and risk of cardiovascular disease—aArhamSheikh1
 
1472 6874-4-s1-s15
1472 6874-4-s1-s151472 6874-4-s1-s15
1472 6874-4-s1-s15ArhamSheikh1
 
Epidemiology of rheumatic heart disease in india
Epidemiology of rheumatic heart disease in indiaEpidemiology of rheumatic heart disease in india
Epidemiology of rheumatic heart disease in indiaDR. VINIT KUMAR
 
Abdulrazak Mohamed Ahmed
Abdulrazak Mohamed AhmedAbdulrazak Mohamed Ahmed
Abdulrazak Mohamed Ahmedekshobd
 
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...Healthcare and Medical Sciences
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.cardiositeindia
 
Burden of depressive disorders by country, sex, age, and year findings from t...
Burden of depressive disorders by country, sex, age, and year findings from t...Burden of depressive disorders by country, sex, age, and year findings from t...
Burden of depressive disorders by country, sex, age, and year findings from t...Lilin Rosyanti Poltekkes kemenkes kendari
 
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...Rishad Choudhury Robin
 
AIDS and Its Oral Manifestation
AIDS and Its Oral ManifestationAIDS and Its Oral Manifestation
AIDS and Its Oral ManifestationDr.Payal Dash
 
Heart disease causes prevention and current
Heart disease causes prevention and currentHeart disease causes prevention and current
Heart disease causes prevention and currentArhamSheikh1
 
Estimation of HIV incidence in Malawi from cross-sectional population-based s...
Estimation of HIV incidence in Malawi from cross-sectional population-based s...Estimation of HIV incidence in Malawi from cross-sectional population-based s...
Estimation of HIV incidence in Malawi from cross-sectional population-based s...Humphrey Misiri
 
Analysis for the global burden of disease study 2016 lancet 2017
Analysis for the global burden of disease study 2016   lancet 2017Analysis for the global burden of disease study 2016   lancet 2017
Analysis for the global burden of disease study 2016 lancet 2017Luis Sales
 

What's hot (18)

Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...
 
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
 
non communicable diseases of india
non communicable diseases of indianon communicable diseases of india
non communicable diseases of india
 
Global Burden of Disease Study - 2010
Global Burden of Disease Study - 2010Global Burden of Disease Study - 2010
Global Burden of Disease Study - 2010
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refs
 
Cardiovascular diseases traditional_and_non-tradit
Cardiovascular diseases traditional_and_non-traditCardiovascular diseases traditional_and_non-tradit
Cardiovascular diseases traditional_and_non-tradit
 
Physical activity and risk of cardiovascular disease—a
Physical activity and risk of cardiovascular disease—aPhysical activity and risk of cardiovascular disease—a
Physical activity and risk of cardiovascular disease—a
 
1472 6874-4-s1-s15
1472 6874-4-s1-s151472 6874-4-s1-s15
1472 6874-4-s1-s15
 
Epidemiology of rheumatic heart disease in india
Epidemiology of rheumatic heart disease in indiaEpidemiology of rheumatic heart disease in india
Epidemiology of rheumatic heart disease in india
 
Abdulrazak Mohamed Ahmed
Abdulrazak Mohamed AhmedAbdulrazak Mohamed Ahmed
Abdulrazak Mohamed Ahmed
 
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...
Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting o...
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.
 
Burden of depressive disorders by country, sex, age, and year findings from t...
Burden of depressive disorders by country, sex, age, and year findings from t...Burden of depressive disorders by country, sex, age, and year findings from t...
Burden of depressive disorders by country, sex, age, and year findings from t...
 
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...
Association Between Passive Smoking & Cardiovascular Disease Among Woman of L...
 
AIDS and Its Oral Manifestation
AIDS and Its Oral ManifestationAIDS and Its Oral Manifestation
AIDS and Its Oral Manifestation
 
Heart disease causes prevention and current
Heart disease causes prevention and currentHeart disease causes prevention and current
Heart disease causes prevention and current
 
Estimation of HIV incidence in Malawi from cross-sectional population-based s...
Estimation of HIV incidence in Malawi from cross-sectional population-based s...Estimation of HIV incidence in Malawi from cross-sectional population-based s...
Estimation of HIV incidence in Malawi from cross-sectional population-based s...
 
Analysis for the global burden of disease study 2016 lancet 2017
Analysis for the global burden of disease study 2016   lancet 2017Analysis for the global burden of disease study 2016   lancet 2017
Analysis for the global burden of disease study 2016 lancet 2017
 

Similar to Stroke journal

Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1RioAlexsandro1
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptxPoojakarki10
 
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...Univ. of Tripoli
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Pubrica
 
Cancer as a causes of death among people with aids
Cancer as a causes of death among people with aidsCancer as a causes of death among people with aids
Cancer as a causes of death among people with aidsAna Paula Bringel
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerDr.Priyanka Sharma
 
Epidemiology of cancer in patients seeking palliative care by l.w. cushny
Epidemiology of cancer in patients seeking palliative care by l.w. cushnyEpidemiology of cancer in patients seeking palliative care by l.w. cushny
Epidemiology of cancer in patients seeking palliative care by l.w. cushnyKesho Conference
 
Mortality rates & standardization
Mortality rates &  standardizationMortality rates &  standardization
Mortality rates & standardizationVaishnavi Madhavan
 
Rajasthan priorities ncds, seshadri
Rajasthan priorities ncds, seshadriRajasthan priorities ncds, seshadri
Rajasthan priorities ncds, seshadriCopenhagen_Consensus
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Clifford Thornton
 
Non communicable diseases in jamaica
Non communicable diseases in jamaicaNon communicable diseases in jamaica
Non communicable diseases in jamaicapaulbourne12
 
CEA_Next_Generation_CVD_Test_-_JME2013
CEA_Next_Generation_CVD_Test_-_JME2013CEA_Next_Generation_CVD_Test_-_JME2013
CEA_Next_Generation_CVD_Test_-_JME2013Jean-Ezra Yeung
 
NEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxNEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxKemi Adaramola
 
Epidemiology of oral cancer
Epidemiology of oral cancerEpidemiology of oral cancer
Epidemiology of oral cancerDr.Payal Dash
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health RegulationSujata Mohapatra
 
Tramadol and the risk of fracture in an elderly female population
Tramadol and the risk of fracture in an elderly female populationTramadol and the risk of fracture in an elderly female population
Tramadol and the risk of fracture in an elderly female populationRubí Bustamante
 
Global Burden of Disease.pptx
Global Burden of Disease.pptxGlobal Burden of Disease.pptx
Global Burden of Disease.pptxSantoshi Paudel
 
Age at cancer diagnosis in Malawi
Age at cancer diagnosis in Malawi Age at cancer diagnosis in Malawi
Age at cancer diagnosis in Malawi Humphrey Misiri
 

Similar to Stroke journal (20)

Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1
 
GBD 2023.pptx
GBD 2023.pptxGBD 2023.pptx
GBD 2023.pptx
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptx
 
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
 
Cancer as a causes of death among people with aids
Cancer as a causes of death among people with aidsCancer as a causes of death among people with aids
Cancer as a causes of death among people with aids
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancer
 
Epidemiology of cancer in patients seeking palliative care by l.w. cushny
Epidemiology of cancer in patients seeking palliative care by l.w. cushnyEpidemiology of cancer in patients seeking palliative care by l.w. cushny
Epidemiology of cancer in patients seeking palliative care by l.w. cushny
 
Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)
 
Mortality rates & standardization
Mortality rates &  standardizationMortality rates &  standardization
Mortality rates & standardization
 
Rajasthan priorities ncds, seshadri
Rajasthan priorities ncds, seshadriRajasthan priorities ncds, seshadri
Rajasthan priorities ncds, seshadri
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
 
Non communicable diseases in jamaica
Non communicable diseases in jamaicaNon communicable diseases in jamaica
Non communicable diseases in jamaica
 
CEA_Next_Generation_CVD_Test_-_JME2013
CEA_Next_Generation_CVD_Test_-_JME2013CEA_Next_Generation_CVD_Test_-_JME2013
CEA_Next_Generation_CVD_Test_-_JME2013
 
NEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxNEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptx
 
Epidemiology of oral cancer
Epidemiology of oral cancerEpidemiology of oral cancer
Epidemiology of oral cancer
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health Regulation
 
Tramadol and the risk of fracture in an elderly female population
Tramadol and the risk of fracture in an elderly female populationTramadol and the risk of fracture in an elderly female population
Tramadol and the risk of fracture in an elderly female population
 
Global Burden of Disease.pptx
Global Burden of Disease.pptxGlobal Burden of Disease.pptx
Global Burden of Disease.pptx
 
Age at cancer diagnosis in Malawi
Age at cancer diagnosis in Malawi Age at cancer diagnosis in Malawi
Age at cancer diagnosis in Malawi
 

Recently uploaded

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Recently uploaded (20)

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 

Stroke journal

  • 1. Journal presentation Dr. Md. Mostafa-Al-Rasel IMO (Medicine) Medicine Unit-5 ShSMCH
  • 2. ‘Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016’ • Source: The New England Journal of Medicine • Date of Publication: December 20, 2018
  • 3. Introduction  Stroke accounts for almost 5% of all disability- adjusted life-years and 10% of all deaths worldwide  The bulk of this burden (>75% of deaths from stroke and >80% of disability-adjusted life-years) occurring in low-income and middle-income countries.  According to several surveys, the global burden of stroke has been increasing, and prevention of stroke may require an improved understanding of the risks among younger persons.  Stroke prevention strategies in low-income and middle-income countries may differ from those adopted in high-income countries owing to differences in access to health care, health technologies, and relative rates of risk factors for stroke.
  • 4. Introduction • Estimates of lifetime risk (defined as the cumulative probability of a disease developing in a person of a given age and sex during that person’s remaining lifespan, after accounting for competing risks of death) provide a measure of disease risk in large populations. • Estimates of lifetime risk of stroke may be useful for the long-term planning of health systems
  • 5. Introduction • Researchers used the results of the Global Burden of Disease (GBD) Study 2016, which estimated major disease burden from 1990 through 2016, to compare the estimated global, regional, and country-specific lifetime risks of stroke in 2016 with those in 1990. • These estimates were stratified according to pathological subtype of stroke, age, sex, and socio- demographic index (SDI) and accounted for the competing risk of death from any cause other than stroke. • The GBD is an ongoing global collaboration that uses all available epidemiologic data to provide a comparative assessment of health loss from 328 diseases across 195 countries and territories.
  • 6. Background • The lifetime risk of stroke has been calculated in a limited number of selected populations. • Diverging trends in stroke incidence and mortality rates have been observed between developed countries (where the rates are decreasing) and developing countries (where the rates are increasing) against a background of increasing life expectancy in almost all countries. • Investigators sought to estimate the lifetime risk of stroke at the regional, country, and global level using data from a comprehensive study of the prevalence of major diseases.
  • 7. Methods • Place of study – global, regional (21 GBD regions nested within 7 GBD super-regions), and national (195 countries) levels • Study period – from 1990 through 2016 • Funded by - the Bill and Melinda Gates Foundation
  • 8. Methods Estimating Stroke Incidence and Mortality  Researchers used estimates from the GBD Study 2016 of the rate of first stroke, cause-specific mortality, and all-cause mortality at the global, regional (21 GBD regions nested within 7 GBD super-regions), and national (195 countries) levels, stratified according to age and sex.  Analyses were performed separately for ischemic stroke and hemorrhagic stroke; the latter included intracerebral hemorrhagic stroke and non traumatic subarachnoid hemorrhagic stroke.
  • 9. Methods Estimating Lifetime Risk of Stroke • Countries were categorized into quintiles of the SDI (high, high-medium, medium, medium-low, and low level of development) used in the GBD Study 2016. • The SDI, a composite indicator of development similar to the Human Development Index, is based on country-level income per capita, average educational attainment among persons older than 15 years of age, and total fertility rate. • Researchers used stroke incidence, prevalence, and mortality rates in each 5-year age group to estimate the lifetime risk of stroke among persons at a given age.
  • 10.  Mortality was estimated by means of the Cause of Death Ensemble model, in which vital registration, verbal autopsy data were considered.  Stroke incidence was estimated with the use of DisMod-MR, a Bayesian meta-regression disease modeling tool. Statistical analysis
  • 11. Statistical analysis • Point estimates and 95% uncertainty intervals representing the 2.5th and 97.5th percentiles around the estimate were used to compare results between groups. • Differences in the estimates of the risk of stroke were considered to be significant when the 95% uncertainty intervals did not overlap or when the 95% uncertainty interval for relative percentage change did not include zero.
  • 13.
  • 14. Results • In 2016, the global lifetime risk of stroke from the age of 25 years onward was 24.9% (95% uncertainty interval, 23.5 to 26.2), and there were regional and between-country differences. • China had the highest estimated risk (39.3%; 95% uncertainty interval, 37.5 to 41.1), and the risks were similarly high in Bosnia and Herzegovina, Bulgaria, Latvia, Macedonia, Montenegro, Romania, and Russia.
  • 15.
  • 16. Results • Among the 21 GBD regions, East Asia had the highest risk (38.8%; 95% uncertainty interval, 37.0 to 40.6), followed by Central Europe (31.7%; 95% uncertainty interval, 30.0 to 33.3) and Eastern Europe (31.6%; 95% uncertainty interval, 27.6 to 35.6); eastern sub-Saharan Africa had the lowest risk (11.8%; 95% uncertainty interval, 10.9 to 12.8).
  • 17.
  • 18. Results • When the risks were compared across SDI quintiles, the high-middle–SDI countries had the greatest risk (31.1%; 95% uncertainty interval, 29.0 to 33.0), followed by the middle- SDI countries (29.3%; 95% uncertainty interval, 27.8 to 30.8); • The low-SDI countries had the lowest risk (13.2%; 95% uncertainty interval, 12.3 to 14.2). • The risk was 23.5% (95% uncertainty interval, 22.2 to 24.8) in high-SDI countries.
  • 19. Results • In 2016, the global lifetime risk of stroke among men (24.7%; 95% uncertainty interval, 23.3 to 26.0) was not significantly different from that among women (25.1%; 95% uncertainty interval, 23.7 to 26.5), but there were regional and between-country differences in sex-specific risk. • The greatest risk among men was in China (41.1%; 95% uncertainty interval 39.2 to 42.9); among women in China, the risk was 36.7% (95% uncertainty interval, 35.0 to 38.6), which accounted for the largest difference in risk between men and women among the nations.
  • 20.
  • 21. Results • The greatest risk among women was in Latvia (41.7%; 95% uncertainty interval, 37.7 to 45.4), and the risks among women in Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Lithuania, Macedonia, Monte-negro, Romania, Russia, Serbia, Slovakia, and Ukraine were similar.
  • 22.
  • 23. Result • The estimates of global lifetime risk of stroke increased from 22.8% in 1990 to 24.9% in 2016, representing a relative increase of 8.9% (95% uncertainty interval, 6.2 to 11.5) • The difference is significant, as reflected by the exclusion of zero in the uncertainty interval. • The increase in the risk was greater among men (15.4%; 95% uncertainty interval, 12.5 to 18.2) than among women (3.2%; 95% uncertainty interval, 0.2 to 6.1), and the increase in the risk of ischemic stroke (12.7%; 95% uncertainty interval, 8.9 to 16.3) was greater than that of hemorrhagic stroke (4.0%; 95% uncertainty interval, 0.2 to 7.6).
  • 24.
  • 25. Discussion • The global lifetime risk of stroke from the age of 25 years onward is estimated to have increased from 22.8% in 1990 to 24.9% in 2016, with the change in the risk of ischemic stroke exceeding that of hemorrhagic stroke. • The estimated global lifetime risk of stroke has declined with increasing age, in part owing to age-related competing risks of other diseases.
  • 26. Discussion • In the comparative risk assessment performed in the GBD Study, elevated blood pressure was estimated as the leading attributable risk factor for stroke across all SDI quintiles, with greater attribution to air pollution and low intake of fruit in low-SDI countries and high body-mass index and high fasting plasma glucose levels in high-SDI countries.
  • 27. Discussion • Knowledge of lifetime risk may be useful for stroke prevention and public education. • High estimates of lifetime risk of stroke suggest that there is possible value of measures for the primary prevention of stroke throughout a person’s lifespan and suggest that strategies to reduce cardiovascular risk remain relevant for both younger and older adults.
  • 28. Strength • The systematic use of data and methods that allow for comparable estimates of lifetime risk of stroke among different locations and between different years. • Researchers provide estimates of lifetime risk of stroke only among persons 25 years of age or older in contrast to other studies that estimated lifetime risk of stroke among persons 45 years of age or older. • Furthermore, the estimates of lifetime risk of stroke that we provide account for competing risk of death from any cause other than stroke and represent whole populations, possibly making the results generalizable.
  • 29. Limitation • The accuracy of the estimates of lifetime risk of stroke was limited by the accuracy and availability of epidemiologic data from the countries studied. • There was a lack of sufficient epidemiologic data on stroke incidence and case fatality for most countries in the world. • In these countries, estimates were dependent on geospatial statistical models that incorporated data from neighboring countries and data on country-level risk exposure.
  • 30. Limitation • Researchers did not differentiate between subarachnoid hemorrhagic and intracerebral hemorrhagic stroke; these were combined in the estimate of hemorrhagic stroke. • Finally, researchers analyzed only the lifetime risk of first-ever stroke and not recurrent stroke.
  • 31. Conclusion • The study provided global, regional, and country-specific estimates of the lifetime risk of stroke according to sex and age. • In 2016, the global lifetime risk of stroke from the age of 25 years onward was approximately 25% among both men and women. • There was geographic variation in the lifetime risk of stroke, with the highest risks in East Asia, Central Europe, and Eastern Europe.